Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
Want to see IN:DRREDDY full AI Analyst Report?
Total Valuation
Dr. Reddy's Laboratories Ltd. has a market cap or net worth of ₹1.09T. The enterprise value is ₹1.15T.
Market Cap₹1.09T
Enterprise Value₹1.15T
Share Statistics
Dr. Reddy's Laboratories Ltd. has 834,617,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding834,617,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.54%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)7.54%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee12.42M
Profits Per Employee1.58M
Employee Count27,048
Asset Turnover0.58
Inventory Turnover2.07
Valuation Ratios
The current PE Ratio of Dr. Reddy's Laboratories Ltd. is 24.4. Dr. Reddy's Laboratories Ltd.’s PEG ratio is -1.01.
PE Ratio24.4
PS Ratio3.11
PB Ratio2.77
Price to Fair Value2.77
Price to FCF34.24
Price to Operating Cash Flow20.06
PEG Ratio-1.01
Income Statement
In the last 12 months, Dr. Reddy's Laboratories Ltd. had revenue of 335.93B and earned 42.85B in profits. Earnings per share was 51.48.
Revenue335.93B
Gross Profit177.26B
Operating Income46.44B
Pretax Income54.82B
Net Income42.85B
EBITDA67.05B
Earnings Per Share (EPS)51.48
Cash Flow
In the last 12 months, operating cash flow was 55.34B and capital expenditures -31.52B, giving a free cash flow of 23.82B billion.
Operating Cash Flow55.34B
Free Cash Flow23.82B
Free Cash Flow per Share28.54
Dividends & Yields
Dr. Reddy's Laboratories Ltd. pays an annual dividend of ₹8, resulting in a dividend yield of 0.63%
Dividend Per Share₹8
Dividend Yield0.63%
Payout Ratio11.38%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change7.86%
50-Day Moving Average1.28K
200-Day Moving Average1.26K
Relative Strength Index (RSI)52.63
Average Volume (3m)225.11K
Important Dates
Dr. Reddy's Laboratories Ltd. upcoming earnings date is Jul 29, 2026, Before Open (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateJul 29, 2026
Ex-Dividend Date―
Financial Position
Dr. Reddy's Laboratories Ltd. as a current ratio of 1.80, with Debt / Equity ratio of 20.51%
Current Ratio1.80
Quick Ratio1.35
Debt to Market Cap0.07
Net Debt to EBITDA0.92
Interest Coverage Ratio12.42
Taxes
In the past 12 months, Dr. Reddy's Laboratories Ltd. has paid 12.35B in taxes.
Income Tax12.35B
Effective Tax Rate0.23
Enterprise Valuation
Dr. Reddy's Laboratories Ltd. EV to EBITDA ratio is 16.50, with an EV/FCF ratio of 36.27.
EV to Sales3.29
EV to EBITDA16.50
EV to Free Cash Flow36.27
EV to Operating Cash Flow20.55
Balance Sheet
Dr. Reddy's Laboratories Ltd. has ₹87.81B in cash and marketable securities with ₹77.34B in debt, giving a net cash position of ₹10.47B billion.
Cash & Marketable Securities₹87.81B
Total Debt₹77.34B
Net Cash₹10.47B
Net Cash Per Share₹12.55
Tangible Book Value Per Share₹315.37
Margins
Gross margin is 52.77%, with operating margin of 13.83%, and net profit margin of 12.76%.
Gross Margin52.77%
Operating Margin13.83%
Pretax Margin16.32%
Net Profit Margin12.76%
EBITDA Margin19.96%
EBIT Margin13.83%
Analyst Forecast
The average price target for Dr. Reddy's Laboratories Ltd. is ₹1,232.50, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target₹1,232.50
Price Target Upside-3.74% Downside
Analyst ConsensusModerate Sell
Analyst Count2
Revenue Growth Forecast3.19%
EPS Growth Forecast-24.26%